| 产品名称: | Human Coxsackievirus A 21 |
|---|---|
| 商品货号: | TS158625 |
| Classification: | Picornaviridae, Enterovirus, Human enterovirus C |
| Deposited As: | coxsackievirus A21 |
| Agent: | Human Coxsackievirus A 21 |
| Strain: | Kuykendall V-024-001-012 |
| Applications: | Respiratory research |
| Biosafety Level: | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Isolation: | Stool from 17 yr. old male with paralytic illness, California, 1952 |
| Product Format: | frozen |
| Storage Conditions: | -70°C or colder |
| Comments: | Derived from NIAID V-024-001-012. A21 may be a natural recombinant between poliovirus and rhinovirus (Shafren et al J. Virol 71:4736,1997; Hughes et al, J.Gen Virol 70:2943,1989) Identical to Coe virus. (Schmidt, NJ et al., Proc. Soc. Exp. Biol. Med. 107: 63, 1961>) Complete destruction of cell sheet in HAm cell cultures occurs within 3 days. A21 is associated with human upper respiratory infections. |
| Effect on Host: | Yes, in vitro effects: Cytopathic effects in tissue culture CPE, cell rounding and sloughing |
| Recommended Host: | human amnion cells Recommended Host: WISH cells (ATCC® CCL-25x99) human amnion cells in tissue culture |
| Growth Conditions: | Duration: 2-3 days |
| Name of Depositor: | NIH/NIAID |
| Source: | Stool from 17 yr. old male with paralytic illness, California, 1952 |
| Year of Origin: | 1952 |
| References: | Sickles GM, et al. New types of Coxsackie virus, group A. Cytopathogenicity in tissue culture. Proc. Soc. Exp. Biol. Med. 102: 742-743, 1959. PubMed: 14446401 |